Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women-Reference-Cited by-同舟云学术

Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women

Published:2022-03-01 Issue:3 Volume:17 Page:277-282
ISSN:1556-8253
Container-title:Breastfeeding Medicine
language:en
Short-container-title:Breastfeeding Medicine

Author:

Baker Teresa E.¹,Croop Robert²,Kamen Lisa²,Price Patty¹,Stock David A.²,Ivans Andrea²,Bhardwaj Rajinder³,Anderson Matt S.³,Madonia Jennifer²,Stringfellow Joseph⁴,Bertz Richard²,Coric Vladimir²,Hale Thomas W.¹^ORCID

Affiliation:

1. Departments of Ob/Gyn and Pediatrics, Texas Tech University Health Sciences Center, Amarillo, Texas, USA.

2. Biohaven Pharmaceuticals, New Haven, Connecticut, USA.

3. Certara USA, Princeton, New Jersey, USA.

4. Navitas Data Sciences, Pottstown, Pennsylvania, USA.

Publisher

Mary Ann Liebert Inc

Subject

Maternity and Midwifery,Obstetrics and Gynecology,Health Policy,Pediatrics

Link

https://www.liebertpub.com/doi/pdf/10.1089/bfm.2021.0250

Reference18 articles.

1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

3. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

4. Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

5. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine;Expert Review of Neurotherapeutics;2024-09-12

2. Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics;The Journal of Headache and Pain;2024-08-28

3. Acute Treatment of Migraine;CONTINUUM: Lifelong Learning in Neurology;2024-04

4. Clinical guidance for choosing the right pharmacotherapy for migraine attacks;Expert Opinion on Pharmacotherapy;2024-01-02

5. What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?;The Journal of Headache and Pain;2023-12-05